Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug, otenaproxesul, is in clinical development as an alternative to opioids and NSAIDs for acute pain. Its second pipeline drug, ATB-352, is being developed for a specialized pain indication. The Company also focuses on inflammatory bowel disease (IBD). Otenaproxesul combines a moiety that releases hydrogen sulfide with naproxen, a non-steroidal, anti-inflammatory drug. ATB-352 is an H2S-releasing derivative of ketoprofen, a potent NSAID commonly prescribed for acute pain. Its IBD candidates are being designed to maintain the efficacy, safety, and pharmacokinetic properties of ATB-429.


GREY:ATBPF - Post by User

Post by RayonPaskon Mar 25, 2018 10:13am
185 Views
Post# 27777253

LETS HELP SPREAD THE WORD

LETS HELP SPREAD THE WORDHi Everyone, I'm new to stockhouse but have been invested in ATE for over a year now. I truly do believe in ATE and would like to see them represent the next generation of pain killers worldwide. As investors, there's only so much we can do to help spread the word about this amazing company. Recently, I've been tagging Antibe Therapeutics @AntibeThera on every relevant twitter account I could think of and it included Donald Trump, the White House, FDA, BNN, CNBC, CNN and a few biotech analysts. I feel all of you should do the same. Either through twitter ,Facebook or any other way you can think of. The exposure will only help and you never know whos watching l. We need more people talking about ATE and getting excited about ATE. Goodluck Everyone 
Bullboard Posts